295 related articles for article (PubMed ID: 19267297)
1. Development and release mechanism of diltiazem HCl prolonged release matrix tablets.
Boyapally H; Nukala RK; Douroumis D
Drug Deliv; 2009 Feb; 16(2):67-74. PubMed ID: 19267297
[TBL] [Abstract][Full Text] [Related]
2. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
[TBL] [Abstract][Full Text] [Related]
3. [Preparation of diltiazem hydrochloride delayed-onset, sustained release tablet].
Zhang N; Zhu JB
Yao Xue Xue Bao; 2002 Sep; 37(9):724-7. PubMed ID: 12567900
[TBL] [Abstract][Full Text] [Related]
4. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
Baviskar D; Sharma R; Jain D
Pak J Pharm Sci; 2013 Jan; 26(1):137-44. PubMed ID: 23261739
[TBL] [Abstract][Full Text] [Related]
5. [Modern polymers in matrix tablets technology].
Zimmer Ł; Kasperek R; Poleszak E
Polim Med; 2014; 44(3):189-96. PubMed ID: 25739125
[TBL] [Abstract][Full Text] [Related]
6. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.
Park JB; Lim J; Kang CY; Lee BJ
Curr Drug Deliv; 2013 Dec; 10(6):732-41. PubMed ID: 23855499
[TBL] [Abstract][Full Text] [Related]
7. Application of similarity factor in development of controlled-release diltiazem tablet.
Peh KK; Wong CF
Drug Dev Ind Pharm; 2000 Jul; 26(7):723-30. PubMed ID: 10872090
[TBL] [Abstract][Full Text] [Related]
8. Advanced formulation design of venlafaxine hydrochloride coated and triple-layer tablets containing hypromellose.
Gohel M; Bariya SH
Pharm Dev Technol; 2009; 14(6):650-8. PubMed ID: 19883254
[TBL] [Abstract][Full Text] [Related]
9. An innovative matrix controlling drug delivery produced by thermal treatment of DC tablets containing polycarbophil and ethylcellulose.
Caviglioli G; Baldassari S; Cirrincione P; Russo E; Parodi B; Gatti P; Drava G
Int J Pharm; 2013 Dec; 458(1):74-82. PubMed ID: 24144954
[TBL] [Abstract][Full Text] [Related]
10. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings.
Lee BJ; Ryu SG; Cui JH
Int J Pharm; 1999 Oct; 188(1):71-80. PubMed ID: 10528084
[TBL] [Abstract][Full Text] [Related]
11. Characterization of 5-fluorouracil release from hydroxypropylmethylcellulose compression-coated tablets.
Wu B; Shun N; Wei X; Wu W
Pharm Dev Technol; 2007; 12(2):203-10. PubMed ID: 17510892
[TBL] [Abstract][Full Text] [Related]
12. A new ternary polymeric matrix system for controlled drug delivery of highly soluble drugs: I. Diltiazem hydrochloride.
Kim H; Fassihi R
Pharm Res; 1997 Oct; 14(10):1415-21. PubMed ID: 9358555
[TBL] [Abstract][Full Text] [Related]
13. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
Sankalia JM; Sankalia MG; Mashru RC
J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
[TBL] [Abstract][Full Text] [Related]
14. Modulation of drug (metoprolol succinate) release by inclusion of hydrophobic polymer in hydrophilic matrix.
Siddique S; Bose A; Khanam J
Drug Dev Ind Pharm; 2011 Sep; 37(9):1016-25. PubMed ID: 21401340
[TBL] [Abstract][Full Text] [Related]
15. Floating elementary osmotic pump tablet (FEOPT) for controlled delivery of diethylcarbamazine citrate: a water-soluble drug.
Khan ZA; Tripathi R; Mishra B
AAPS PharmSciTech; 2011 Dec; 12(4):1312-23. PubMed ID: 21969244
[TBL] [Abstract][Full Text] [Related]
16. In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices.
Bravo SA; Lamas MC; Salamón CJ
J Pharm Pharm Sci; 2002; 5(3):213-9. PubMed ID: 12553888
[TBL] [Abstract][Full Text] [Related]
17. Drug-polymer mixed coating: a new approach for controlling drug release rates in pellets.
Nisar ur Rahman ; Yuen KH; Khan NA; Wong JW
Pharm Dev Technol; 2006 Feb; 11(1):71-7. PubMed ID: 16544910
[TBL] [Abstract][Full Text] [Related]
18. [Optimization of the formulation of ranolazine hydrochloride sustained-release tablet and its pharmacokinetics in dogs].
Li CJ; Yu YL; Yang QM; Li Y; Zhang YH; Wang JY
Yao Xue Xue Bao; 2010 Sep; 45(9):1170-6. PubMed ID: 21351575
[TBL] [Abstract][Full Text] [Related]
19. Formulation development and evaluation of Diltiazem HCl sustained release matrix tablets using HPMC K4M and K100M.
Qazi F; Shoaib MH; Yousuf RI; Qazi TM; Mehmood ZA; Hasan SM
Pak J Pharm Sci; 2013 Jul; 26(4):653-63. PubMed ID: 23811439
[TBL] [Abstract][Full Text] [Related]
20. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
Košir D; Vrečer F
Drug Dev Ind Pharm; 2017 Feb; 43(2):329-337. PubMed ID: 27739880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
